{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T08:45:31Z","timestamp":1775378731097,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000261","name":"Multiple Sclerosis Society of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000261","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004381","name":"Western University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004381","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jneuroim.2023.578267","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T15:24:24Z","timestamp":1702653864000},"page":"578267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Systemic administration of anti-CD20 indirectly reduces B cells in the inflamed meninges in a chronic model of central nervous system autoimmunity"],"prefix":"10.1016","volume":"387","author":[{"given":"Yodit","family":"Tesfagiorgis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eden A.","family":"Kemal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather C.","family":"Craig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate A.","family":"Parham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M.","family":"Kerfoot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2023.578267_bb0005","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.151683","article-title":"Accumulation of meningeal lymphocytes correlates with white matter lesion activity in progressive multiple sclerosis","volume":"7","author":"Ahmed","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.jneuroim.2023.578267_bb0010","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nri1786","article-title":"Lymphoid neogenesis in chronic inflammatory diseases","volume":"6","author":"Aloisi","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2023.578267_bb0015","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/ana.24651","article-title":"Rituximab versus fingolimod after natalizumab in multiple sclerosis patients: rituximab vs Fingolimod","volume":"79","author":"Alping","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2023.578267_bb0020","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/ana.21363","article-title":"Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase I trial","volume":"63","author":"Bar-Or","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2023.578267_bb0025","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.clim.2015.03.009","article-title":"Central nervous system infiltrates are characterized by features of ongoing B cell-related immune activity in MP4-induced experimental autoimmune encephalomyelitis","volume":"158","author":"Batoulis","year":"2015","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2023.578267_bb0030","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1172\/JCI28334","article-title":"Myelin oligodendrocyte glycoprotein\u2013specific T and B cells cooperate to induce a Devic-like disease in mice","volume":"116","author":"Bettelli","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2023.578267_bb0035","first-page":"8","article-title":"Anti-CD20 depletes meningeal B cells but does not halt the formation of meningeal ectopic lymphoid tissue","author":"Brand","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jneuroim.2023.578267_bb0040","doi-asserted-by":"crossref","first-page":"6864","DOI":"10.3390\/ijms21186864","article-title":"Obinutuzumab-induced B cell depletion reduces spinal cord pathology in a CD20 double transgenic mouse model of multiple sclerosis","volume":"21","author":"Breakell","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2023.578267_bb0045","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.4049\/jimmunol.1501376","article-title":"Autoreactive CD19+ CD20\u2212 plasma cells contribute to disease severity of experimental autoimmune encephalomyelitis","volume":"196","author":"Chen","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2023.578267_bb0050","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.2353\/ajpath.2006.060626","article-title":"Persistent macrophage\/microglial activation and myelin disruption after experimental autoimmune encephalomyelitis in tissue inhibitor of metalloproteinase-1-deficient mice","volume":"169","author":"Crocker","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jneuroim.2023.578267_bb0055","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jneuroim.2006.06.029","article-title":"Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients","volume":"180","author":"Cross","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2023.578267_bb0060","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jneuroim.2014.12.008","article-title":"B cell recognition of myelin oligodendrocyte glycoprotein autoantigen depends on immunization with protein rather than short peptide, while B cell invasion of the CNS in autoimmunity does not","volume":"278","author":"Dang","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2023.578267_bb0065","first-page":"6","article-title":"Meningeal infiltration of the spinal cord by non-classically activated B cells is associated with chronic disease course in a spontaneous B Cell-dependent model of CNS autoimmune disease","author":"Dang","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2023.578267_bb0070","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3389\/fimmu.2015.00470","article-title":"Meningeal infiltration of the spinal cord by non-classically activated B cells is associated with chronic disease course in a spontaneous B cell-dependent model of CNS autoimmune disease","volume":"6","author":"Dang","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2023.578267_bb0075","first-page":"12","article-title":"CNS-draining meningeal lymphatic vasculature: roles, conundrums and future challenges","author":"das Neves","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jneuroim.2023.578267_bb0080","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1073\/pnas.1519608113","article-title":"Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease","volume":"113","author":"Flach","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2023.578267_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061478","article-title":"Secondary B cell receptor diversification is necessary for T cell mediated neuro-inflammation during experimental autoimmune encephalomyelitis","volume":"8","author":"Galicia","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2023.578267_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2014.05.010","article-title":"B cell follicle-like structures in multiple sclerosis-with focus on the role of B cell activating factor","volume":"273","author":"Haugen","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2023.578267_bb0095","article-title":"B-cell depletion with rituximab in relapsing\u2013remitting multiple sclerosis","volume":"13","author":"Hauser","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2023.578267_bb0100","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa1601277","article-title":"Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis","volume":"376","author":"Hauser","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2023.578267_bb0105","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1056\/NEJMoa1917246","article-title":"Ofatumumab versus teriflunomide in multiple sclerosis","volume":"383","author":"Hauser","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2023.578267_bb0110","doi-asserted-by":"crossref","first-page":"9773","DOI":"10.1073\/pnas.1810470115","article-title":"Functional characterization of reappearing B cells after anti-CD20 treatment of CNS autoimmune disease","volume":"115","author":"H\u00e4usler","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2023.578267_bb0115","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1093\/brain\/awr182","article-title":"Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis","volume":"134","author":"Howell","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2023.578267_bb0120","first-page":"e54727","article-title":"Simple and efficient production and purification of mouse myelin oligodendrocyte glycoprotein for experimental autoimmune encephalomyelitis studies","volume":"116","author":"Jain","year":"2016","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.jneuroim.2023.578267_bb0125","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1016\/j.celrep.2018.11.070","article-title":"Autoreactive, low-affinity T cells preferentially drive differentiation of short-lived memory B cells at the expense of germinal center maintenance","volume":"25","author":"Jain","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.jneuroim.2023.578267_bb0130","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0140-6736(11)61649-8","article-title":"Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial","volume":"378","author":"Kappos","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2023.578267_bb0135","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1172\/JCI28330","article-title":"Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell\/B cell cooperation","volume":"116","author":"Krishnamoorthy","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2023.578267_bb0140","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00401-012-1023-3","article-title":"Tertiary lymphoid organ development coincides with determinant spreading of the myelin-specific T cell response","volume":"124","author":"Kuerten","year":"2012","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"10.1016\/j.jneuroim.2023.578267_bb0145","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/acn3.71","article-title":"Intrathecal anti-CD20 efficiently depletes meningeal B cells in CNS autoimmunity","volume":"1","author":"Lehmann-Horn","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jneuroim.2023.578267_bb0150","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/1521-4141(200207)32:7<1905::AID-IMMU1905>3.0.CO;2-L","article-title":"Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein","volume":"32","author":"Lyons","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2023.578267_bb0155","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/brain\/awm038","article-title":"Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology","volume":"130","author":"Magliozzi","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2023.578267_bb0160","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1007\/s00415-021-10744-x","article-title":"Anti-CD20 therapies for multiple sclerosis: current status and future perspectives","volume":"269","author":"Margoni","year":"2022","journal-title":"J. Neurol."},{"issue":"10","key":"10.1016\/j.jneuroim.2023.578267_bb0165","first-page":"3420","article-title":"Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression","volume":"118","author":"Matsushita","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2023.578267_bb0170","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/bjh.15132","article-title":"New insights in type I and II CD20 antibody mechanisms-of-action with a panel of novel CD20 antibodies","volume":"180","author":"Meyer","year":"2018","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jneuroim.2023.578267_bb0175","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1093\/brain\/awab093","article-title":"Formation and immunomodulatory function of meningeal B cell aggregates in progressive CNS autoimmunity","volume":"144","author":"Mitsdoerffer","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2023.578267_bb0180","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/archneur.62.2.258","article-title":"Effect of rituximab on the peripheral blood and cerebrospinal fluid B cells in patients with primary progressive multiple sclerosis","volume":"62","author":"Monson","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2023.578267_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017103","article-title":"Rituximab therapy reduces organ-specific T cell responses and ameliorates experimental autoimmune encephalomyelitis","volume":"6","author":"Monson","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2023.578267_bb0190","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJMoa1606468","article-title":"Ocrelizumab versus placebo in primary progressive multiple sclerosis","volume":"376","author":"Montalban","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2023.578267_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-023-05551-3","article-title":"Microglia and meningeal macrophages depletion delays the onset of experimental autoimmune encephalomyelitis","volume":"14","author":"Montilla","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jneuroim.2023.578267_bb0200","series-title":"Th17 Cells Induce Ectopic Lymphoid Follicles in Central Nervous System Tissue Inflammation","volume":"20","author":"Peters","year":"2011"},{"key":"10.1016\/j.jneuroim.2023.578267_bb0205","first-page":"67","article-title":"Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis","author":"Piccio","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2023.578267_bb0210","first-page":"113488","article-title":"Subcutaneous anti-CD20 antibody treatment delays gray matter atrophy in human myelin oligodendrocyte glycoprotein-induced EAE mice","author":"Pol","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2023.578267_bb0215","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/bpa.12841","article-title":"B cell rich meningeal inflammation associates with increased spinal cord pathology in multiple sclerosis","volume":"30","author":"Reali","year":"2020","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jneuroim.2023.578267_bb0220","first-page":"8","article-title":"Anti-CD20 disrupts meningeal B-Cell aggregates in a model of secondary progressive multiple sclerosis","author":"Roodselaar","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jneuroim.2023.578267_bb0225","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1750-3639.2004.tb00049.x","article-title":"Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis","volume":"14","author":"Serafini","year":"2004","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jneuroim.2023.578267_bb0230","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/NEN.0b013e3181e332ec","article-title":"Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation","volume":"69","author":"Serafini","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2023.578267_bb0235","first-page":"62","article-title":"Clinical Stabilization And Effective B-Lymphocyte depletion in the cerebrospinal fluid and peripheral blood of a patient with fulminant relapsing-remitting multiple sclerosis","author":"St\u00fcve","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2023.578267_bb0240","doi-asserted-by":"crossref","first-page":"449","DOI":"10.4049\/jimmunol.1602042","article-title":"Activated B cells participating in the anti-myelin response are excluded from the inflamed central nervous system in a model of autoimmunity that allows for B cell recognition of autoantigen","volume":"199","author":"Tesfagiorgis","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2023.578267_bb0245","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/ana.22081","article-title":"B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity: B cells in CNS autoimmunity","volume":"68","author":"Weber","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2023.578267_bb0250","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S1474-4422(20)30342-2","article-title":"Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial","volume":"19","author":"Wolinsky","year":"2020","journal-title":"Lancet Neurol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572823002539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572823002539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:42:47Z","timestamp":1759048967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572823002539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":50,"alternative-id":["S0165572823002539"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578267","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.01.22.427667","asserted-by":"object"}]},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic administration of anti-CD20 indirectly reduces B cells in the inflamed meninges in a chronic model of central nervous system autoimmunity","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578267","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"578267"}}